Adenosine
Adenosine.JPG

Adenosine

CLINICAL USE

  • Rapid reversion to sinus rhythm of paroxysmal supraventricular tachycardias
  • Diagnosis of broad or narrow complex supraventricular tachycardias

    DOSE IN NORMAL RENAL FUNCTION

    Initially: 3 mg over 2 seconds with cardiac monitoring followed, if necessary, by 6 mg after 1–2 minutes and then by 12 mg after a further 1–2 minutes

    PHARMACOKINETICS

  • Molecular weight                           : 267.2
  • %Protein binding                           : 0
  • %Excreted unchanged in urine     : <5
  • Volume of distribution (L/kg)       : No data
  • half-life – normal/ESRD (hrs)      :
  • <10           : seconds/ Unchanged

    DOSE IN RENAL IMPAIRMENT

    GFR (mL/MIN)

  • 20 to 50     : Dose as in normal renal function
  • 10 to 20     : Dose as in normal renal function
  • <10           : Dose as in normal renal function

    DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES

  • CAPD                : Not dialysed. Dose as in normal renal function
  • HD                     : Not dialysed. Dose as in normal renal function
  • HDF/high flux   : Unknown dialysability. Dose as in normal renal function
  • CAV/VVHD      : Not dialysed. Dose as in normal renal function

    IMPORTANT DRUG INTERACTIONS

    Potentially hazardous interactions with other drugs
  • Anti-arrhythmics: increased risk of myocardial depression
  • Antipsychotics: increased risk of ventricular arrhythmias with antipsychotics that prolong the QT interval
  • Beta-blockers: increased risk of myocardial depression
  • Effect is enhanced and extended by dipyridamole; therefore if use of adenosine is essential, dosage should be reduced by a factor of 4 (i.e. initial dosage of 0.5–1 mg)
  • Theophylline and other xanthines are potent inhibitors of adenosine

    ADMINISTRATION

    Reconstition

    Route

    IV

    Rate of Administration

    Rapid IV bolus (see dose)

    Comments

    Do not refrigerate Administer into central vein, large peripheral vein, or into an IV line. If IV line used, follow dose by rapid sodium chloride 0.9% flush

    OTHER INFORMATION

  • Neither the kidney nor the liver is involved in the degradation of exogenous adenosine, so dose adjustments are not required in hepatic or renal insufficiency
  • Unlike verapamil, adenosine may be used in conjunction with a beta-blocker
  • Common side effects: facial flushing, chest pain, dyspnoea, bronchospasm, nausea and lightheadedness; the side effects are short-lived



    See how to identify renal failure stages according to GFR calculation

    See how to diagnose irreversible renal disease

    Home

  • other drugs